In heart failure, non-coding RNAs, particularly miRNAs encapsulated in extracellular vesicles (EV), influence the redox balance in the myocardium and brain by regulating the NRF2 signaling pathway
Patients with certain FTO and MC4R variants, for example, often show enhanced appetite suppression and weight loss when using dual GLP-1/GIP receptor agonists like tirzepatide, potentially allowing metformin reduction or discontinuation more rapidly
Coagonistas GLP-1/glucagn El desarrollo de estas formulaciones unimoleculares con efecto sobre los receptores de GLP-1 y glucagn aporta potenciacin del efecto anorexiante de GLP-1, efecto lipoltico e inhibidor de la lipognesis (tabla 2), particularmente a nivel heptico, y accin termognica, facilitando la reduccin ponderal y el tratamiento de MASLD1,5,35
The weight-loss benefits of these drugs have led to their prescribed use for obesity or overweight treatment
Nieuw onderzoek laat zien dat je meer vet verteert bij licht intensieve inspanning, dus ga wandelen of joggen
Build the foundation firstsolid nutrition, consistent exercise, adequate sleepthen consider whether supplements provide marginal additional benefits worth pursuing
